Elevated C-reactive protein levels in schizophrenia inpatients is associated with aggressive behavior

European Psychiatry

Volumn 31, Issue , 2016, Pages 8-12

  Barzilay, R ^a   Lobel, T ^a   Krivoy, A ^a   Shlosberg, D ^a   Weizman, A ^a   Katz, N ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Aggression; C reactive protein; Inflammation; Neutrophil to lymphocyte ratio; Schizophrenia; Suicidal behavior

Indexed keywords

C REACTIVE PROTEIN; BIOLOGICAL MARKER;

ADULT; AGED; AGGRESSION; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HOSPITAL PATIENT; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; NEUTROPHIL LYMPHOCYTE RATIO; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SCHIZOPHRENIA; SUICIDAL BEHAVIOR; BLOOD; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PSYCHOLOGY; RESTLESSNESS; SUICIDAL IDEATION;

ADULT; AGGRESSION; BIOMARKERS; C-REACTIVE PROTEIN; FEMALE; HUMANS; INPATIENTS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PSYCHOMOTOR AGITATION; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SUICIDAL IDEATION;

EID: 84953221452     PISSN: 09249338     EISSN: 17783585     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2015.09.461     Document Type: Article

References (34)

1. Dack C., Ross J., Papadopoulos C., Stewart D., Bowers L. A review and meta-analysis of the patient factors associated with psychiatric in-patient aggression. Acta Psychiatr Scand 2013, 127:255-268. 10.1111/acps.12053.
2. Krakowski M., Czobor P., Chou J.C.Y. Course of violence in patients with schizophrenia: relationship to clinical symptoms. Schizophr Bull 1999, 25:505-517.
3. Barlow K., Grenyer B., Ilkiw-Lavalle O. Prevalence and precipitants of aggression in psychiatric inpatient units. Aust New Zeal J Psychiatry 2000, 34:967-974. 10.1080/000486700271.
4. Marsland A.L., Prather A.A., Petersen K.L., Cohen S., Manuck S.B. Antagonistic characteristics are positively associated with inflammatory markers independently of trait negative emotionality. Brain Behav Immun 2008, 22:753-761. 10.1016/j.bbi.2007.11.008.
5. Coccaro E.F. Association of C-reactive protein elevation with trait aggression and hostility in personality disordered subjects: a pilot study. J Psychiatr Res 2006, 40:460-465. 10.1016/j.jpsychires.2005.04.005.
6. Coccaro E.F., Lee R., Coussons-Read M. Elevated plasma inflammatory markers in individuals with intermittent explosive disorder and correlation with aggression in humans. JAMA Psychiatry 2014, 71:158-165. 10.1001/jamapsychiatry.2013.3297.
7. Coccaro E.F., Lee R., Coussons-Read M. Cerebrospinal fluid and plasma C-reactive protein and aggression in personality-disordered subjects: a pilot study. J Neural Transm 2015, 122:321-326. 10.1007/s00702-014-1263-6.
8. Lindqvist D., Janelidze S., Hagell P., Erhardt S., Samuelsson M., Minthon L., et al. Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity. Biol Psychiatry 2009, 66:287-292. 10.1016/j.biopsych.2009.01.030.
9. Janelidze S., Mattei D., Westrin Å., Träskman-Bendz L., Brundin L. Cytokine levels in the blood may distinguish suicide attempters from depressed patients. Brain Behav Immun 2011, 25:335-339. 10.1016/j.bbi.2010.10.010.
10. O'Donovan A., Rush G., Hoatam G., Hughes B.M., McCrohan A., Kelleher C., et al. Suicidal ideation is associated with elevated inflammation in patients with major depressive disorder. Depress Anxiety 2013, 30:307-314. 10.1002/da.22087.
11. Dickerson F., Stallings C., Origoni A., Vaughan C., Khushalani S., Yang S., et al. C-reactive protein is elevated in schizophrenia. Schizophr Res 2013, 143:198-202. 10.1016/j.schres.2012.10.041.
12. Dickerson F., Stallings C., Origoni A., Boronow J., Yolken R. C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia. Schizophr Res 2007, 93:261-265. 10.1016/j.schres.2007.03.022.
13. Fan X., Pristach C., Liu E.Y., Freudenreich O., Henderson D.C., Goff D.C. Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia. Psychiatry Res 2007, 149:267-271. 10.1016/j.psychres.2006.07.011.
14. Akanji A.O., Ohaeri J.U., Al-Shammri S., Fatania H.R. Association of blood levels of C-reactive protein with clinical phenotypes in Arab schizophrenic patients. Psychiatry Res 2009, 169:56-61. 10.1016/j.psychres.2008.06.010.
15. Solanki R.K., Singh P., Singh M., Sinha M., Swami M.K., Saini S. C-reactive protein (CRP) in patients with schizophrenia: are they related with symptomatology?. J Ment Heal Hum Behav 2010, 6:1-5.
16. Fawzi M.H., Fawzi M.M., Fawzi M.M., Said N.S. C-reactive protein serum level in drug-free male Egyptian patients with schizophrenia. Psychiatry Res 2011, 190:91-97. 10.1016/j.psychres.2011.05.010.
17. Zahorec R. Ratio of neutrophil to lymphocyte counts - rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 2001, 102:5-14.
18. Ridker P.M. Cardiology patient page. C-reactive protein: a simple test to help predict risk of heart attack and stroke. Circulation 2003, 108:e81-e85. 10.1161/01.CIR.0000093381.57779.67.
19. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13:261-276.
20. Lindenmayer J.-P., Brown E., Baker R.W., Schuh L.M., Shao L., Tohen M., et al. An excitement subscale of the Positive and Negative Syndrome Scale. Schizophr Res 2004, 68:331-337. 10.1016/S0920-9964(03)00087-2.
21. Huber C.G., Lambert M., Naber D., Schacht A., Hundemer H.-P., Wagner T.T., et al. Validation of a Clinical Global Impression Scale for Aggression (CGI-A) in a sample of 558 psychiatric patients. Schizophr Res 2008, 100:342-348. 10.1016/j.schres.2007.12.480.
22. Montoya A., Valladares A., Lizán L., San L., Escobar R., Paz S. Validation of the Excited Component of the Positive and Negative Syndrome Scale (PANSS-EC) in a naturalistic sample of 278 patients with acute psychosis and agitation in a psychiatric emergency room. Health Qual Life Outcomes 2011, 9:18. 10.1186/1477-7525-9-18.
23. Valkanova V., Ebmeier K.P., Allan C.L. CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J Affect Disord 2013, 150:736-744. 10.1016/j.jad.2013.06.004.
24. Gassmann-Mayer C., Jiang K., McSorley P., Arani R., Dubrava S., Suryawanshi S., et al. Clinical and statistical assessment of suicidal ideation and behavior in pharmaceutical trials. Clin Pharmacol Ther 2011, 90:554-560. 10.1038/clpt.2011.144.
25. Rosell D.R., Siever L.J. The neurobiology of aggression and violence. CNS Spectr 2015, 20:254-279. 10.1017/S109285291500019X.
26. Hoptman M.J. Impulsivity and aggression in schizophrenia: a neural circuitry perspective with implications for treatment. CNS Spectr 2015, 20:280-286. 10.1017/S1092852915000206.
27. Coccaro E.F., Lee R., Gozal D. Elevated plasma oxidative stress markers in individuals with intermittent explosive disorder and correlation with aggression in humans. Biol Psychiatry 2014, 10.1016/j.biopsych.2014.01.014.
28. Beurel E., Jope R.S. Inflammation and lithium: clues to mechanisms contributing to suicide-linked traits. Transl Psychiatry 2014, 4:e488. 10.1038/tp.2014.129.
29. Baumeister D., Akhtar R., Ciufolini S., Pariante C.M., Mondelli V. Childhood trauma and adulthood inflammation: a meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-α. Mol Psychiatry 2015, 10.1038/mp.2015.67.
30. Swanson J.W., Swartz M.S., Van Dorn R.A., Elbogen E.B., Wagner H.R., Rosenheck R.A., et al. A national study of violent behavior in persons with schizophrenia. Arch Gen Psychiatry 2006, 63:490-499. 10.1001/archpsyc.63.5.490.
31. Dickerson F., Stallings C., Origoni A., Vaughan C., Khushalani S., Yolken R. Additive effects of elevated C-reactive protein and exposure to herpes simplex virus type 1 on cognitive impairment in individuals with schizophrenia. Schizophr Res 2012, 134:83-88. 10.1016/j.schres.2011.10.003.
32. Hope S., Dieset I., Agartz I., Steen N.E., Ueland T., Melle I., et al. Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia. J Psychiatr Res 2011, 45:1608-1616. 10.1016/j.jpsychires.2011.08.003.
33. Collins A.A., Remington G., Coulter K., Birkett K. Depression in schizophrenia: a comparison of three measures. Schizophr Res 1996, 20:205-209.
34. Kalia M., Costa E., Silva J. Biomarkers of psychiatric diseases: current status and future prospects. Metabolism 2015, 64:S11-S15. 10.1016/j.metabol.2014.10.026.